FDA.reportPublic FDA data

beremagene geperpavec-svdt 5,000,000,000 UNT/ML Topical Suspension

RxCUI
2637762
RxNorm name
beremagene geperpavec-svdt 5,000,000,000 UNT/ML Topical Suspension
Display name
beremagene geperpavec-svdt 5,000,000,000 UNT/ML Topical Suspension
Full name
beremagene geperpavec-svdt 5,000,000,000 UNT/ML Topical Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:29

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125774VYJUVEKberemagene geperpavec-svdt351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VYJUVEKVYJUVEKKrystal Biotech, Inc.fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c22025-09-29Warnings, Adverse reactionsExact identifier
rxcui: 2637762

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c2beremagene geperpavec-svdt 5,000,000,000 UNT/ML Topical SuspensionSY6These highlights do not include all the information needed to use VYJUVEK safely and effectively. See full prescribing information for VYJUVEK. VYJUVEK® (beremagene geperpavec-svdt) biological suspension mixedwith excipient gel for topical applicationInitial U.S. Approval: 202320250929
fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c2beremagene geperpavec-svdt 5,000,000,000 PFU/ML Topical SuspensionPSN6These highlights do not include all the information needed to use VYJUVEK safely and effectively. See full prescribing information for VYJUVEK. VYJUVEK® (beremagene geperpavec-svdt) biological suspension mixedwith excipient gel for topical applicationInitial U.S. Approval: 202320250929
fe207c8c-04b4-4fdf-87cf-6dbc7eb6e9c2beremagene geperpavec-svdt 5000000000 UNT/ML Topical SuspensionSCD6These highlights do not include all the information needed to use VYJUVEK safely and effectively. See full prescribing information for VYJUVEK. VYJUVEK® (beremagene geperpavec-svdt) biological suspension mixedwith excipient gel for topical applicationInitial U.S. Approval: 202320250929